American International Group’s vTv Therapeutics VTVT Stock Holding History

American International Group’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-173	Closed	-$19	–	3279
2021 Q1	$19	Buy	173 +13	+8%	+$1.28K	﹤0.01%	3126
2020 Q4	$12	Buy	160 +4	+3%	+$307	﹤0.01%	3126
2020 Q3	$11K	Buy	156 +8	+5%	+$703	﹤0.01%	3096
2020 Q2	$13K	Buy	+148	New	+$14.6K	﹤0.01%	3065
2018 Q2	–	Sell	-113	Closed	-$18K	–	3120
2018 Q1	$18K	Sell	113 -6	-5%	-$1.47K	﹤0.01%	2996
2017 Q4	$29K	Hold	119	–	–	﹤0.01%	2993
2017 Q3	$28K	Buy	119 +9	+8%	+$1.79K	﹤0.01%	2822
2017 Q2	$22K	Sell	110 -8	-7%	-$1.67K	﹤0.01%	3049
2017 Q1	$31K	Buy	118 +8	+7%	+$1.82K	﹤0.01%	2918
2016 Q4	$21K	Hold	110	–	–	﹤0.01%	2965
2016 Q3	$31.7K	Hold	110	–	–	﹤0.01%	2967
2016 Q2	$25.5K	Buy	110 +23	+26%	+$5.29K	﹤0.01%	3042
2016 Q1	$18K	Buy	+87	New	+$21.7K	﹤0.01%	4342

Other funds holding VTVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAG

Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

American International Group's VTVT Position: Q2 2021 in Review

American International Group sold out of vTv Therapeutics (VTVT) in Q2 2021, closing a stake of 173 shares — an estimated $19 sold.

American International Group first reported a position in VTVT in Q1 2016 and held it in 13 quarters. The position peaked at $31.7K in Q3 2016. 42 funds tracked by Wall St. Rank hold VTVT as of Q2 2021.

American International Group reported no remaining vTv Therapeutics position as of Q2 2021 after selling out during the quarter.
American International Group sold 173 vTv Therapeutics shares in Q2 2021, an estimated $19.
American International Group first reported a position in vTv Therapeutics in Q1 2016 and held it in 13 quarters.
American International Group's vTv Therapeutics position peaked at $31.7K in Q3 2016.
42 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.